Belgium· BE-AMP-SAM154296-00
Magnevist 0,5 mmol/ml
A gadopentetsäure product containing gadopentetate dimeglumine, registered in Belgium by Bayer. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Gadopentetsäure is registered in 3 of 19 countries.
Countries holding a registration under ATC V08CA01 (gadopentetsäure), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Gadopentetsäure · ATC V08CA01
3 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Gadopentetate Dimeglumine
- Manufacturer
- Bayer
- Country
- Belgium (BE)
- ATC code
- V08CA01
- ATC class
- Gadopentetsäure
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb1414598
- be_apb0749069
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gadopentetsäure in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyMagnevistEurocontrast Gmbh
- CanadaMAGNEVISTBAYER INC
- SwedenMagnevist 2 mmol/l Injektionsvätska, lösning i förfylld sprutaBayer AB
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Germany · Magnevist
- United Kingdom (Northern Ireland) · Magnevist
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fc4caf7b-fe43-412c-990f-8c11c83c8d50 GET /v1/drugs/fc4caf7b-fe43-412c-990f-8c11c83c8d50?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "REVOKED",
"name_en": "Magnevist 0,5 mmol/ml",
"name_fr": "Magnevist 0,5 mmol/ml",
"name_nl": "Magnevist 0,5 mmol/ml",
"amp_code": "SAM154296-00",
"strengths": [
"469.0000"
],
"pack_count": 1,
"substances": [
"Gadopentetate Dimeglumine"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Gadopentetic Acid",
"authorisation_numbers": [
"BE154296"
]
}See everything about gadopentetsäure.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.